Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 648-655

  Maio, Raffaele ^a   Sciacqua, Angela ^a   Bruni, Rosamaria ^a   Pascale, Alessandra ^a   Carullo, Giuseppe ^a   Scarpino, Paola E ^a   Addesi, Desirée ^a   Spinelli, Ines ^a   Leone, Giulia Galiano ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; DOSE RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; GLOMERULUS FILTRATION RATE; GROUPS BY AGE AND SEX; HOMEOSTASIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPH; RISK FACTOR; VASODILATATION;

ACETYLCHOLINE; ADULT; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEMOGLOBINS; HUMANS; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; ITALY; LINEAR MODELS; MALE; MIDDLE AGED; NITROPRUSSIDE; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 79952995833     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06920810     Document Type: Article

References (32)

1. Luscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. Boca Raton, FL, CRC Press, 1990, pp 1-215
2. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO: Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91: 1732-1738, 1995
3. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191-196, 2001 (Pubitemid 32655837)
4. Hingorani AD: Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 5: 19-25, 2003
5. Perticone F, Ceravolo R, Maio R, Ventura G, Zingone A, Perrotti N, Mattioli PL: Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension 31: 900-905, 1998 (Pubitemid 28185565)
6. Perticone F, Sciacqua A, Barlassina C, Del Vecchio L, Signorello MC, Dal Fiume C, Andreozzi F, Sesti G, Cusi D: Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens 25: 2234-2239, 2007 (Pubitemid 47537916)
7. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A: Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998 (Pubitemid 28265383)
8. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, Szalai AJ, Ward ME, Verma S: Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis 201: 318-325, 2008
9. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G, Zoccali C: Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46: 518-523, 2005 (Pubitemid 41040296)
10. Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C: Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb Haemost 84: 553-558, 2000
11. Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC: Haemoglobin targets: We were wrong, time to move on. Lancet 369: 346-350, 2007 (Pubitemid 46188478)
12. Zoccali C, Kielstein JT: Asymmetric dimethylarginine: A new player in the pathogenesis of renal disease? Curr Opin Nephrol Hypertens 15: 314-320, 2006
13. Cirillo M, Laurenzi M, Trevisan M, Stamler J Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 20: 319-326, 1992
14. Neunteufl T, Heher S, Stefenelli T, Pabinger I, Gisslinger H: Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol 115: 354-359, 2001 (Pubitemid 34203502)
15. Levey AS, Bosch JP, Breyer LJ, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999 (Pubitemid 29135798)
16. Sciacqua A, Scozzafava A, Pujia A, Maio R, Borrello F, Andreozzi F, Vatrano M, Cassano S, Perticone M, Sesti G, Perticone F: Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension. Eur Heart J 26: 921-927, 2005 (Pubitemid 40676573)
17. Kleinbaum DG, Kupper LL, Muller KE, Nizam A: Applied Regression Analysis and Other Multivariable Methods, 3rd Ed., Washington, DC, Duxbury Press, 2000
18. Perticone F, Maio R, Tripepi G, Zoccali C: Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 110: 821-852, 2004
19. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F: Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17: 1466-1471, 2006 (Pubitemid 43673429)
20. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS: The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 96: 9027-9032, 1999 (Pubitemid 29374701)
21. Butler AR, Megson IL, Wright PG: Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1425: 168-176, 1998 (Pubitemid 28479723)
22. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-Nitroso haemoglobin: A dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996 (Pubitemid 26090643)
23. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA: Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997 (Pubitemid 27443606)
24. Huang KT, Han TH, Hyduke DR, Vaughn MW, Van Herle H, Hein TW, Kuo L, Liao JC: Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A 98: 11771-11776, 2001 (Pubitemid 32928804)
25. McMahon TJ, Pawloski JR, Hess DT, Piantadosi CA, Luchsinger BP, Dingel DJ, Stamler JJ: S-Nitrosohemoglobin is distinguished from other nitrosovasodilators by unique oxygen-dependent responses that support an allosteric mechanism of action. Blood 102: 410-411, 2003
26. Schechter AN, Gladwin MT: Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 348: 1483-1485, 2003 (Pubitemid 36407180)
27. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB: Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 115: 3409-3417, 2005 (Pubitemid 43121829)
28. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO III, Schechter AN, Gladwin MT: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8: 1383-1389, 2002 (Pubitemid 36019423)
29. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293: 1653-1662, 2005 (Pubitemid 40471796)
30. Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E: Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J 26: 464-471, 2005 (Pubitemid 40314762)
31. Madsen PL, Scheuermann Freestone M, Neubauer S, Channon K, Clarke K: Haemoglobin and flow-mediated vasodilation. Clin Sci (Lond) 110: 467-473, 2006
32. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S: Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 157: 527-536, 2009